gastroparesis caused by glp 1 Adverse effects of GLP-1 class drugs. Gastrointestinal issues are Sulfur burps on GLP-1 medications:

The SURMOUNT-1 trial showed participants losing up to 22.5% of their body weight on the highest dose, compared to approximately 15-17% with semaglutide in the STEP trials

doi: 10.1016/s0002-9343(01)00651-9

Birnbaum W, Bertelloni S (2014) Sex hormone replacement in disorders of sex development

In addition to regaining weight, people returned to pre-drug levels of key markers of cardiometabolic health including blood pressure and cholesterol about 17 months after coming off all weight-loss drugs

Schedule a consultation to map out whats working, whats missing, and what your next steps should be

More studies are needed in preterm infants to know whether routine supplementation of L-carnitine in neonates requiring total parenteral nutrition for a long time would provide any clinical benefit